Beyond Air Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors

Go back to Beyond Air Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors
(NASDAQ: XAIR) Delayed: 3.53 -0.06 (1.67%)
Previous Close $3.59    52 Week High
Open $3.55    52 Week Low
Day High $3.64    P/E N/A 
Day Low $3.50    EPS
Volume 48,545